[1] Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson’s disease [J]. J Parkinsons Dis, 2013, 3(4): 461-491.
[2] Morrison BE. Discovery of nigral dopaminergic neurogenesis in adult mice [J]. Neural Regen Res, 2016, 11(6): 878-881.
[3] Gomez-Lazaro M, Bonekamp NA, Galindo MF, et al. 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells [J]. Free Radic Biol Med, 2008, 44(11): 1960-1969.
[4] Miloso M, Villa D, Crimi M, et al. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent[J]. J Neurosci Res, 2004, 75(2): 241-252.
[5] Adeosun SO, Hou X, Jiao Y, et al. Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson’s disease[J]. PLoS One,2012, 7(11): e50040.
[6] Wang JM, Brinton RD. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential[J]. BMC Neurosci, 2008, 9 (Suppl 2):S11.
[7] Zhang P, Qi ShSh, Xie MQ, et al. Effect of allopregnanolone on the dopaminergic neurons in the substania nigra of APPswe/PSEN1 mice [J]. Acta Anatomica Sinica, 2015,46(3):317-323.(in Chinese)
张鹏,戚双双,谢明琦,等. 别孕烯醇酮对APPswe/PSEN1小鼠黑质多巴胺能神经元的影响[J]. 解剖学报, 2015,46(3):317-323.
[8] Sun C, Ou X, Farley JM, et al. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of triple transgenic mouse model of Alzheimer’s disease [J]. Curr Alzheimer Res, 2012, 9(4):473-480.
[9] Gonzalez, SL,Meyer, L, Raggio, MC, et al. Allopregnanolone and progesterone in experimental neuropathic pain: former and new insights with a translational perspective[J]. Cell Mol Neurobiol, 2019, 39(4): 523-537.
[10] Wang JM, Singh C, Liu L, et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer’s disease[J]. Proc Natl Acad Sci, 2010,107(14):6498-6503.
[11] Fukunaga K, Miyamoto E. A working model of CaM kinase Ⅱ activity in hippocampal long-term potentiation and memory [J]. Neurosci Res, 2000, 38(1): 3-17.
[12] Jagasia R, Steib K, Englberger E, et al. GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus[J]. J Neurosci, 2009, 29(25): 7966-7977.
[13] Cunha MP, Martin-de-Saavedra MD, Romero A, et al. Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma Sh-Sy5y cells:involvement of intracellular signaling pathway[J]. Neuroscience, 2013, 238:185-194.
[14] Wang JM, Johnston PB, Ball BG, et al. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression [J]. J Neurosci, 2005, 25(19): 4706-4718.
[15] Wang JM. Allopregnanolone and neurogenesis in the nigrostriatal tract [J]. Front Cell Neurosci, 2014, 8(8):224.
[16] Charalampopoulos Ⅰ, Remboutsika E, Margioris AN, et al. Neurosteroids as modulators of neurogenesis and neuronal survival[J]. Trends Endocrinol Metab, 2008, 19(8): 300-307.
[17] Shioda N, Sawai M, Ishizuka Y, et al. Nuclear translocation of calcium/calmodulin- dependent protein kinase Ⅱδ3 promoted by protein phosphatase-1 enhances brain- derived neurotrophic factor expression in dopaminergic neurons[J]. J Biol Chem, 2015, 290(35):21663-21675.
[18] Takeuchi Y, Fukunaga K, Miyamoto E. Activation of nuclear Ca2+/calmodulin-dependent protein kinase Ⅱ and brain-derived neurotrophic factor gene expression by stimulation of dopamine D2 receptor in transfected NG108-15 cells[J]. J Neurochem, 2002, 82(2): 316-328.
[19] Sasi M, Vignoli B, Canossa M, et al. Neurobiology of local and intercellular BDNF signaling[J]. Pflugers Arch, 2017, 469(5-6): 593-610.
|